Trial Profile
Pharmacokinetics of a Single Dulaglutide Dose in Healthy Chinese Subjects and of Multiple Dulaglutide Doses in Chinese Patients With T2DM
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2021
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 17 Nov 2021 Results published in the Advances in Therapy
- 30 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jun 2014 Planned End Date changed from 1 Aug 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.